No connection

Search Results

SENS

BEARISH
$6.77 Live
Senseonics Holdings, Inc. · NASDAQ
Target $18.92 (+179.4%)
$5.25 52W Range $15.74
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 19, 2026
Market cap
$283.01M
P/E
N/A
ROE
-168.3%
Profit margin
-196.0%
Debt/Equity
0.68
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
SENS exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company shows impressive top-line revenue growth of 71.80% and maintains a strong liquidity position (Current Ratio 4.83), these are offset by a devastating profit margin of -196.03% and a consistent track record of missing earnings estimates. The stock is in a long-term bearish trend with a 5-year decline of 81.7%, suggesting that the market is discounting the growth in favor of the unsustainable burn rate.

Key Strengths

Strong YoY revenue growth of 71.80%
High liquidity with a Current Ratio of 4.83
Positive Gross Margin of 44.71% indicating product viability
Manageable Debt/Equity ratio of 0.68
Significant bullish gap between current price ($6.77) and analyst target ($18.92)

Key Risks

Critical financial health (Piotroski F-Score 1/9)
Severe negative profitability (Profit Margin -196.03%)
Poor earnings track record with 0/4 beats in the last year
High valuation relative to sales (P/S Ratio 8.03) for a non-profitable firm
Persistent long-term price depreciation (-81.7% over 5 years)
AI Fair Value Estimate
Based on comprehensive analysis
$6.2
-8.4% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
25
Weak
Value
25
Future
65
Past
15
Health
20
Dividend
0
AI Verdict
High-Risk Speculative Growth
Key drivers: Extreme revenue growth, Severe operational losses, Strong cash runway, Technical breakdown
Confidence
90%
Value
25/100

No Graham Number available due to negative earnings; valuation is purely speculative based on growth.

Positives
  • Low market cap provides high upside potential if pivoted
Watchpoints
  • P/S of 8.03 is expensive for a company with -196% margins
  • P/B of 4.58 is high given the lack of earnings
Future
65/100

Growth is strong on the top line, but failing to translate to the bottom line.

Positives
  • 71.8% YoY revenue growth
  • Strong analyst price targets suggesting future adoption
Watchpoints
  • Negative EPS growth trends
  • Consistent failure to meet earnings expectations
Past
15/100

Historical performance is overwhelmingly negative across price and earnings.

Positives
  • Successful product launch/market entry evidenced by revenue
Watchpoints
  • 5-year return of -81.7%
  • Chronic earnings misses over 25 quarters
Health
20/100

Liquidity is the only saving grace; operational health is critical.

Positives
  • Strong Current Ratio (4.83) provides a safety buffer
Watchpoints
  • Piotroski F-Score of 1/9 is a major red flag
  • ROE of -168.27% indicates massive equity erosion
Dividend
0/100

Dividend Yield: N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • No capacity for dividends given losses

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.77
Analyst Target
$18.92
Upside/Downside
+179.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for SENS and closest competitors.

Updated 2026-04-17
SEN
Senseonics Holdings, Inc.
Primary
5Y
-81.7%
3Y
-46.7%
1Y
-43.6%
6M
-17.0%
1M
+6.8%
1W
+1.4%
ANL
Adlai Nortye Ltd.
Peer
5Y
-47.0%
3Y
-47.0%
1Y
+247.2%
6M
+345.4%
1M
-14.4%
1W
-10.8%
CLP
ClearPoint Neuro, Inc.
Peer
5Y
-59.8%
3Y
-1.5%
1Y
-17.2%
6M
-65.6%
1M
-21.4%
1W
-0.3%
MAS
908 Devices Inc.
Peer
5Y
-85.9%
3Y
-13.6%
1Y
+62.9%
6M
-8.5%
1M
+18.6%
1W
+5.1%
OBI
Orchestra BioMed Holdings, Inc.
Peer
5Y
-56.0%
3Y
-79.2%
1Y
+62.1%
6M
+24.9%
1M
+0.4%
1W
+7.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-2.57
PEG Ratio
N/A
P/B Ratio
4.58
P/S Ratio
8.03
EV/Revenue
6.53
EV/EBITDA
-3.44
Market Cap
$283.01M

Profitability

Profit margins and return metrics

Profit Margin -196.03%
Operating Margin -146.78%
Gross Margin 44.71%
ROE -168.27%
ROA -37.68%

Growth

Revenue and earnings growth rates

Revenue Growth +71.8%
Earnings Growth N/A
Q/Q Revenue Growth +71.82%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.68
Moderate
Current Ratio
4.83
Strong
Quick Ratio
4.37
Excellent
Cash/Share
$2.25

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
53.8%
Op. Margin
-146.8%
Net Margin
-146.1%
Total Assets
$0.1B
Liabilities
$0.1B
Equity
$0.1B
Debt/Equity
1.07x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
102%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-07
$N/A
2026-03-02
$-0.46
-6.1% surprise
2025-11-05
$-0.43
-6.7% surprise
2025-08-06
$-0.4

Healthcare Sector Comparison

Comparing SENS against 447 companies in the Healthcare sector (26 bullish, 140 neutral, 281 bearish)
Return on Equity (ROE)
-168.27%
This Stock
vs
-97.42%
Sector Avg
+72.7% (Excellent)
Profit Margin
-196.03%
This Stock
vs
-14.95%
Sector Avg
+1211.2% (Superior)
Debt to Equity
0.68
This Stock
vs
3.06
Sector Avg
-77.8% (Less Debt)
Revenue Growth
71.8%
This Stock
vs
147.85%
Sector Avg
-51.4% (Slower)
Current Ratio
4.83
This Stock
vs
4.68
Sector Avg
+3.2% (Better)

Similar Companies

Peer comparison within the same industry

SENS Senseonics Holdings, Inc.
BEARISH
Mkt Cap
$283M
P/E
-
ROE
-168.3%
Price
$6.77
ANL Adlai Nortye Ltd.
BEARISH
Mkt Cap
$293M
P/E
-
ROE
-139.0%
Price
$7.95
 Compare with SENS
CLPT ClearPoint Neuro, Inc.
BEARISH
Mkt Cap
$270M
P/E
-
ROE
-95.6%
Price
$9.07
 Compare with SENS
MASS 908 Devices Inc.
BEARISH
Mkt Cap
$269M
P/E
-
ROE
-25.8%
Price
$7.2
 Compare with SENS
OBIO Orchestra...
NEUTRAL
Mkt Cap
$267M
P/E
-
ROE
-109.4%
Price
$4.57
 Compare with SENS

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

PRINCE DOUGLAS S
Director
Stock Award
2026-04-01
1,221 shares · $8,120
STEVEN EDELMAN VICTOR
Director
Stock Award
2026-04-01
1,936 shares · $12,874
FIORENTINO EDWARD J
Director
Stock Award
2026-04-01
2,124 shares · $14,125
ROEDER DOUGLAS A
Director
Stock Award
2026-04-01
2,218 shares · $14,750
GOODNOW TIMOTHY TODD
Chief Executive Officer
Buy
2026-03-13
17,225 shares · $99,733
ROEDER DOUGLAS A
Director
Buy
2026-03-13
17,500 shares · $100,275
STEVEN EDELMAN VICTOR
Director
Stock Award
2026-01-02
2,185 shares · $12,870
FIORENTINO EDWARD J
Director
Stock Award
2026-01-02
2,398 shares · $14,124
ROEDER DOUGLAS A
Director
Stock Award
2026-01-02
2,504 shares · $14,749
PRINCE DOUGLAS S
Director
Stock Award
2026-01-02
1,379 shares · $8,122
STEVEN EDELMAN VICTOR
Director
Buy
2025-11-10
10,000 shares · $65,500
SULLIVAN FREDERICK T
Chief Financial Officer
Buy
2025-11-07
5,415 shares · $31,840
GOODNOW TIMOTHY TODD
Chief Executive Officer
Buy
2025-11-07
17,210 shares · $101,023
ROEDER DOUGLAS A
Director
Buy
2025-11-07
15,000 shares · $87,450
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-06

SENS filed a definitive proxy statement on April 6, 2026, providing shareholders with information and voting materials for its upcoming annual meeting.

8-K
FORM 8-K
2026-03-12

Senseonics, Inc. filed an 8-K, likely reporting its annual financial results for the fiscal year ended December 31, 2025.

8-K
8-K
2026-03-02

Senseonics, Inc. filed a current report on March 2, 2026, likely announcing its annual financial results.

10-K
10-K
2026-03-02

SENS filed its 10-K on March 2, 2026, providing comprehensive updates on its business operations and financial condition. The filing includes detailed disclosures regarding the company's risk factors and management's analysis of operational results.

8-K
FORM 8-K
2026-01-12
8-K
FORM 8-K
2026-01-02
10-Q
10-Q
2025-11-05

Senseonics is transitioning commercial responsibility for Eversense from Ascensia back to the company, with U.S. operations expected to resume on January 1, 2026. Key risks include uncertainty regarding the final negotiated terms and potential liabilities associated with the transition, as well as pending government approvals in certain European markets.

8-K
8-K
2025-11-05

Senseonics, Inc. filed an 8-K on November 5, 2025, likely to announce its third-quarter financial results.

8-K
FORM 8-K
2025-10-16

Senseonics, Inc. (SENS) filed an 8-K likely reporting its third-quarter financial results for 2025.

8-K
FORM 8-K
2025-10-07

Senseonics, Inc. filed a Form 8-K on October 7, 2025, likely reporting third-quarter financial results or a material corporate update.

8-K
FORM 8-K
2025-10-06
8-K
FORM 8-K
2025-09-30
8-K
FORM 8-K
2025-09-04
DEF 14A
DEF 14A
2025-08-18
10-Q
10-Q
2025-08-06
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
6 analysts
HC Wainwright & Co.
2025-11-06
Maintains
Buy Buy
TD Cowen
2025-11-05
Maintains
Buy Buy
Barclays
2025-11-05
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning SENS from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile